$28.53
0.652.33%
Last update: Nov 6, 4:00 PM
Parabilis Medicines Inc
PBLSNASDAQ
The average analyst price target for Parabilis Medicines is $41.25, 44.6% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $40 to $45. The latest change came on Oct 22, 2026, when HC Wainwright & Co. initiated coverage of Parabilis Medicines with a Buy rating and a $40 price target.
Price Target Range — 2 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
